시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의료기기 상환 시장 보고서(2025년)
Medical Devices Reimbursement Global Market Report 2025
상품코드 : 1825448
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 의료기기 상환 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 9.0%로 확대되어 9,147억 7,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 가치 기반 건강 관리 모델, 정밀의료에 대한 수요 증가, 세계적인 의료 안보 노력, 환자 중심 관리에 대한 주력, 의료 기술 평가(HTA)와의 협력, 건강 관리에 대한 정부 투자 등에 기인할 수 있습니다. 예측기간의 주요 동향으로는 디지털 헬스 기술의 통합, 제조업체와 지불자의 협업 계약, 리얼 월드 에비덴스와 의료 경제 데이터의 중시, 성과 보상 모델의 채용, 가치 평가 프레임워크의 도입, 리스크 분담 계약의 진전 등을 들 수 있습니다.

향후 5년간의 성장률 9.0%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 이스라엘과 캐나다에서 조달한 인공지능(AI) 주도 상환 소프트웨어 및 청구 처리 도구의 비용을 증가시켜 보험자의 승인을 늦추거나 의료 서비스 제공업체의 관리 오버헤드를 높여 미국을 방해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

저침습 수술에 대한 수요 증가는 의료기기 상환 시장의 성장을 가속할 것으로 예측됩니다. 저침습 수술(MIS)은 기존의 개복 수술에 비해 환자의 신체 장애를 줄이고 수술을 수행하기 위해 특수 기술과 도구를 사용하는 의료 접근법입니다. 저침습 수술에 대한 의료기기의 상환은 고급 수술에 대한 환자 접근의 향상과 입원 기간의 단축에 의한 헬스케어 비용의 삭감 등의 이점을 가져옵니다. 예를 들어, 미국에 본사를 둔 미국 성형외과학회(ASPS)는 2023년 9월 A형 보툴리눔툭신(보톡스, 디스포트, 제오민 포함)를 사용한 저침습 수술이 2023년 471만 5,716건 진행되어 전년 대비 6% 증가했다고 보고했습니다. 게다가 피부 필러가 널리 사용되고 344만 1,534건의 시술이 이루어졌으며 2022년부터 4% 증가했습니다. 따라서 저침습 수술에 대한 수요가 증가함에 따라 의료기기 상환 시장의 성장이 뒷받침되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.

The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The medical device reimbursement market research report is one of a series of new reports from The Business Research Company that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $648.71 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.

The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $914.77 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.

The forecast of 9.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Artificial intelligence(AI)-driven reimbursement software and claims processing tools sourced from Israel and Canada, thereby delaying insurer approvals and elevating administrative overhead for healthcare providers. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.

Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.

In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.

Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance

North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Devices Reimbursement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical devices reimbursement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical devices reimbursement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Devices Reimbursement Market Characteristics

3. Medical Devices Reimbursement Market Trends And Strategies

4. Medical Devices Reimbursement Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Devices Reimbursement Growth Analysis And Strategic Analysis Framework

6. Medical Devices Reimbursement Market Segmentation

7. Medical Devices Reimbursement Market Regional And Country Analysis

8. Asia-Pacific Medical Devices Reimbursement Market

9. China Medical Devices Reimbursement Market

10. India Medical Devices Reimbursement Market

11. Japan Medical Devices Reimbursement Market

12. Australia Medical Devices Reimbursement Market

13. Indonesia Medical Devices Reimbursement Market

14. South Korea Medical Devices Reimbursement Market

15. Western Europe Medical Devices Reimbursement Market

16. UK Medical Devices Reimbursement Market

17. Germany Medical Devices Reimbursement Market

18. France Medical Devices Reimbursement Market

19. Italy Medical Devices Reimbursement Market

20. Spain Medical Devices Reimbursement Market

21. Eastern Europe Medical Devices Reimbursement Market

22. Russia Medical Devices Reimbursement Market

23. North America Medical Devices Reimbursement Market

24. USA Medical Devices Reimbursement Market

25. Canada Medical Devices Reimbursement Market

26. South America Medical Devices Reimbursement Market

27. Brazil Medical Devices Reimbursement Market

28. Middle East Medical Devices Reimbursement Market

29. Africa Medical Devices Reimbursement Market

30. Medical Devices Reimbursement Market Competitive Landscape And Company Profiles

31. Medical Devices Reimbursement Market Other Major And Innovative Companies

32. Global Medical Devices Reimbursement Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Devices Reimbursement Market

34. Recent Developments In The Medical Devices Reimbursement Market

35. Medical Devices Reimbursement Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기